Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Erika Carmel-TechXTAE:ERKA 32 Net Margin % is -23.91% as of Dec. 2025. GuruFocus rates XTAE:ERKA with a GF Score™ of 32/100 and a GF Value™ of ₪0.55 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Erika Carmel-Tech ranks worse than 66.79% on this metric.
The historical rank and industry rank for Erika Carmel-Tech's Net Margin % or its related term are showing as below:
XTAE:ERKA'
s Net Margin % Range Over the Past 10 Years
Min: -64.71 Med: -19.1 Max: 14.53
Current: -15.68
XTAE:ERKA's Net Margin % is ranked worse than 66.79% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.11
vs XTAE:ERKA: -15.68
Erika Carmel-Tech (XTAE:ERKA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Erika Carmel-Tech Net Margin % Related Terms
Erika Carmel-Tech Net Margin % Historical Data
* Premium members only.
The historical data trend for Erika Carmel-Tech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ERKA vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Erika Carmel-Tech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Erika Carmel-Tech Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Erika Carmel-Tech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Erika Carmel-Tech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Erika Carmel-Tech (XTAE:ERKA) has a Net Margin % of -23.91% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Erika Carmel-Tech and its competitors. According to the industry distribution chart, Erika Carmel-Tech ranks #545 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 66.8%.
Is Erika Carmel-Tech's Net Margin % too high?
Erika Carmel-Tech's current Net Margin % is -23.91%. Based on the distribution chart, Erika Carmel-Tech ranks #545 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Erika Carmel-Tech has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Erika Carmel-Tech ranks #545 out of 816 companies for Net Margin %. This places Erika Carmel-Tech in the lower half of its industry. The industry median Net Margin % is 2.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.11, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Erika Carmel-Tech and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Erika Carmel-Tech's current Net Margin % is -23.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Fairly Valued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.52 — trading 6.4% below its estimated fair value. The current Net Margin % is -23.91%. Erika Carmel-Tech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current Net Margin % is -23.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?
Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued.
The current stock price of ₪0.52 is trading 6.4% below its estimated GF Value™ of ₪0.55.
GuruFocus considers Erika Carmel-Tech to be Fairly Valued.
Key valuation signals for XTAE:ERKA:
Net Margin %: -23.91%
GF Value™: ₪0.55 vs. price of ₪0.52 (6.4% below fair value)
No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
32GF Score
Get the complete analysis for XTAE:ERKA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ERKA has been successfully added to your 
